Screener
Royalty Pharma RPRX Provision for credit losses on unfunded commitments
Provision for credit losses on unfunded commitments at other companies
Other financials
Where this comes from
Reported directly by Royalty Pharma in its filing.
Tagged under the XBRL concept rprx:ProvisionForCreditLossesOnUnfundedCommitments.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total income and other revenues | 674,141 | 578,665 | 1,304,717 | 1,146,912 |
| Operating expense/(income) | ||||
| Provision for changes in expected cash flows from financial royalty assets | 268,216 | (203,938) | 70,732 | (331,078) |
| Provision for credit losses on unfunded commitments | 13,068 | 92,535 | 9,368 | 92,535 |
| Research and development funding expense | 97,851 | 300,500 | 137,641 | 351,000 |
| General and administrative expenses (includes $107,356 and $91,044 of share-based compensation expense for the three months ended June 30, 2026 and 2025, respectively, and $229,648 and $91,747 for the six months ended June 30, 2026 and 2025, respectively; see Note 4) | 161,887 | 179,769 | 321,377 | 290,475 |
| Financial royalty asset impairment | — | — | 69,443 | — |
| Total operating expense, net | 541,022 | 368,866 | 608,561 | 402,932 |
Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Royalty Pharma's provision for credit losses on unfunded commitments?
- Royalty Pharma (RPRX) reported provision for credit losses on unfunded commitments of $13.07M in Q2 2026.
- How has Royalty Pharma's provision for credit losses on unfunded commitments changed year-over-year?
- Royalty Pharma's provision for credit losses on unfunded commitments decreased by 85.9% year-over-year, from $92.54M to $13.07M.
- What does provision for credit losses on unfunded commitments mean?
- An accounting charge representing the estimated credit losses associated with off-balance sheet commitments to fund future development-stage products. This reflects the firm's exposure to the creditworthiness of its development partners.
Ask your AI about Royalty Pharma's provision for credit losses on unfunded commitments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude